FDA Week
CDER Director Janet Woodcock comments on FDA experience with user fees during Food and Drug Law Institute panel moderated by Catalyst's Nancy Myers "Woodcock Expresses Concern With Too Much Reliance On User Fees" (subscription required) This article focuses on comments made by CDER Director Janet Woodcock, MD, during a panel on user fees at the Food